Antonaci, Laura
 Distribuzione geografica
Continente #
NA - Nord America 1.152
AS - Asia 915
EU - Europa 769
SA - Sud America 201
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 3.064
Nazione #
US - Stati Uniti d'America 1.101
SG - Singapore 510
CN - Cina 179
BR - Brasile 163
IT - Italia 159
SE - Svezia 158
FR - Francia 108
DE - Germania 99
IE - Irlanda 59
GB - Regno Unito 41
ID - Indonesia 35
VN - Vietnam 34
CA - Canada 27
IN - India 25
RU - Federazione Russa 23
FI - Finlandia 21
PL - Polonia 21
NL - Olanda 18
TR - Turchia 18
AR - Argentina 15
BD - Bangladesh 15
HK - Hong Kong 14
KR - Corea 14
MX - Messico 14
IQ - Iraq 13
JP - Giappone 13
IR - Iran 10
RO - Romania 10
BE - Belgio 8
ZA - Sudafrica 8
AT - Austria 7
ES - Italia 7
LT - Lituania 6
PA - Panama 6
CH - Svizzera 5
EC - Ecuador 5
IL - Israele 5
AE - Emirati Arabi Uniti 4
PK - Pakistan 4
UA - Ucraina 4
UZ - Uzbekistan 4
BG - Bulgaria 3
BO - Bolivia 3
CO - Colombia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
JO - Giordania 3
KZ - Kazakistan 3
MA - Marocco 3
OM - Oman 3
PY - Paraguay 3
TN - Tunisia 3
VE - Venezuela 3
BY - Bielorussia 2
CI - Costa d'Avorio 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
DZ - Algeria 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.064
Città #
Singapore 272
Chandler 190
Ashburn 159
New York 78
Beijing 46
Dublin 45
Los Angeles 43
Rome 43
Hefei 34
Jakarta 34
Munich 31
Dallas 26
Boston 25
Marseille 24
Milan 24
Princeton 21
San Mateo 19
Frankfurt am Main 18
Denver 16
São Paulo 16
Moscow 14
Nuremberg 14
Seoul 14
Buffalo 13
Hong Kong 13
Montreal 13
Helsinki 12
Warsaw 12
Atlanta 11
Chicago 11
Ho Chi Minh City 11
Orem 11
Santa Clara 11
Amsterdam 10
Ann Arbor 10
Houston 10
Bremen 9
Palermo 9
Düsseldorf 8
Kent 8
Portsmouth 8
The Dalles 8
Tokyo 8
Ankara 7
Brussels 7
Hanoi 7
London 7
Wilmington 7
Baghdad 6
Belo Horizonte 6
Hyderabad 6
Johannesburg 6
Menlo Park 6
Mexico City 6
Seattle 6
Stockholm 6
Dhaka 5
Fairfield 5
Falkenstein 5
Kish 5
Lappeenranta 5
Poplar 5
Salvador 5
Toronto 5
Washington 5
Wroclaw 5
Augusta 4
Bexley 4
Brasília 4
Brescia 4
Charlotte 4
Chennai 4
Council Bluffs 4
Gustavo Adolfo Madero 4
Haiphong 4
Paris 4
Phoenix 4
Pittsburgh 4
Redwood City 4
Rio de Janeiro 4
Salt Lake City 4
Shanghai 4
Turku 4
Amman 3
Andover 3
Boardman 3
Brooklyn 3
Changsha 3
Columbus 3
Grottaferrata 3
La Paz 3
Las Vegas 3
Londrina 3
Manchester 3
Mumbai 3
Norwalk 3
Pune 3
Redmond 3
San Francisco 3
Secaucus 3
Totale 1.664
Nome #
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 134
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 133
Predominant distal muscle involvement in spinal muscular atrophy 129
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen 120
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy 116
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 115
A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophy 113
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 112
Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome? 107
Does albuterol have an effect on neuromuscular junction dysfunction in spinal muscular atrophy? 106
Early treatment of type II SMA slows rate of progression of scoliosis 103
MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients 103
Nusinersen in pediatric and adult patients with type III spinal muscular atrophy 103
New therapies for spinal muscular atrophy: where we stand and what is next 98
Long-term progression in type II spinal muscular atrophy: A retrospective observational study 97
Clinical Variability in Spinal Muscular Atrophy Type III. 94
Long-term progression in type II spinal muscular atrophy: A retrospective observational study 91
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 91
Development of an academic disease registry for spinal muscular atrophy 89
P.222Long term progression in type II spinal muscular atrophy: a retrospective observational study 87
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis 86
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis 85
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial 84
Sleep disorders in spinal muscular atrophy 81
Patient and parent oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in SMA. Rome, 13 July 2019 81
Long term follow-up of scoliosis progression in type II SMA patients 77
Communicative development inventory in type 1 and presymptomatic infants with spinal muscular atrophy: a cohort study 73
Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study (Neurology and Therapy, (2023), 12, 2, (543-557), 10.1007/s40120-023-00444-1) 72
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 68
Long-term progression in type II spinal muscular atrophy: A retrospective observational study 68
Profile of cognitive abilities in spinal muscular atrophy type II and III: what is the role of motor impairment? 63
Caregivers’ Expectations on Possible Functional Changes following Disease-Modifying Treatment in Type II and III Spinal Muscular Atrophy: A Comparative Study 63
Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey? 62
Totale 3.104
Categoria #
all - tutte 15.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 4 5 0 0 3 5 0
2021/2022241 14 4 5 44 18 8 6 31 18 16 38 39
2022/2023537 50 78 31 86 29 66 30 50 75 5 20 17
2023/2024383 7 82 12 35 12 80 28 23 1 30 34 39
2024/2025796 12 14 53 41 70 42 46 24 119 86 161 128
2025/20261.103 252 38 110 260 364 79 0 0 0 0 0 0
Totale 3.104